Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Steward

Showing results (161-170 of 256) with videos related to

Pageof 26
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 20, 2005
Concomitant chemoradiotherapy for muscle-invasive bladder cancer: the way forward for bladder preservation?B T Sherwood, G D D Jones, J K Mellon, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 26, 2003
Liquid chromatographic assay for the simultaneous determination of indole-3-carbinol and its acid condensation products in plasmaMark J Anderton, Rebekah Jukes, John H Lamb, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 25, 2004
Physiological modeling of formulated and crystalline 3,3'-diindolylmethane pharmacokinetics following oral administration in miceMark J Anderton, Margaret M Manson, Richard Verschoyle, et al.
Cancer Treatment Reports|September 1, 1987
Phase I clinical trial of methylene dimethane sulfonateD B Smith, B W Fox, N Thatcher, et al.
Seminars in Oncology|June 13, 2003
Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584Anne L Thomas, Bruno Morgan, Joachim Drevs, et al.
British Journal of Cancer|April 26, 2000
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancerK J O'Byrne, M I Koukourakis, A Giatromanolaki, et al.
Investigational New Drugs|March 1, 2006
Effects of the potential chemopreventive agent DMU-135 on adenoma development in the ApcMin+ mouseS Sale, R G Tunstall, K C Ruparelia, et al.
British Journal of Cancer|February 1, 1989
Prognostic factors in high and intermediate grade non-Hodgkin's lymphomaR A Cowan, M Jones, M Harris, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer: report of a phase I/II dose-escalating studyA L Thomas, G Cox, R A Sharma, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
The use of recombinant human granulocyte-macrophage colony-stimulating factor with combination chemotherapy in the treatment of advanced adult soft-tissue sarcomas: early results from the EORTC Soft-Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.
Pageof 26

Showing results (161-170 of 256) with videos related to

Sort By:
Pageof 26
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 20, 2005
Concomitant chemoradiotherapy for muscle-invasive bladder cancer: the way forward for bladder preservation?B T Sherwood, G D D Jones, J K Mellon, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 26, 2003
Liquid chromatographic assay for the simultaneous determination of indole-3-carbinol and its acid condensation products in plasmaMark J Anderton, Rebekah Jukes, John H Lamb, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 25, 2004
Physiological modeling of formulated and crystalline 3,3'-diindolylmethane pharmacokinetics following oral administration in miceMark J Anderton, Margaret M Manson, Richard Verschoyle, et al.
Cancer Treatment Reports|September 1, 1987
Phase I clinical trial of methylene dimethane sulfonateD B Smith, B W Fox, N Thatcher, et al.
Seminars in Oncology|June 13, 2003
Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584Anne L Thomas, Bruno Morgan, Joachim Drevs, et al.
British Journal of Cancer|April 26, 2000
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancerK J O'Byrne, M I Koukourakis, A Giatromanolaki, et al.
Investigational New Drugs|March 1, 2006
Effects of the potential chemopreventive agent DMU-135 on adenoma development in the ApcMin+ mouseS Sale, R G Tunstall, K C Ruparelia, et al.
British Journal of Cancer|February 1, 1989
Prognostic factors in high and intermediate grade non-Hodgkin's lymphomaR A Cowan, M Jones, M Harris, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer: report of a phase I/II dose-escalating studyA L Thomas, G Cox, R A Sharma, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
The use of recombinant human granulocyte-macrophage colony-stimulating factor with combination chemotherapy in the treatment of advanced adult soft-tissue sarcomas: early results from the EORTC Soft-Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.
Pageof 26